Search results
Results from the WOW.Com Content Network
New Covid boosters from Pfizer and Moderna designed to target the XBB.1.5 subvariant have been approved by the US Food and Drug Administration and are expected to be made available later this week.
New Covid boosters approved as CDC set to decide who should receive them amid rising cases Monday 11 September 2023 19:38 , Graeme Massie Health officials say that the Pfizer and Moderna shots ...
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
Health officials say that the Pfizer and Moderna shots likely to be available later this week
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
Without insurance or other financial assistance, Moderna’s new jab will cost $129, Pfizer’s $120, and Novavax’s $130 per dose, company representatives said at Tuesday’s CDC committee hearing.
The U.S. Food and Drug Administration (FDA) approved updated COVID-19 booster shots today, setting the stage for a fall vaccine push to combat the still-circulating virus.
The CDC has recommended updated Covid booster shots from Pfizer and Moderna. The shots target the original virus and omicron subvariants BA.4 and BA.5.